What a $480,000-a-year cancer drug means for employer health coverage
Rasonque’s approval is an exciting development in the fight to cure cancer, but could further challenge employers to carefully manage use.
Find out why health insurance is a critical focus for today's people leaders and recruiters.
Rasonque’s approval is an exciting development in the fight to cure cancer, but could further challenge employers to carefully manage use.
Improved health, including fewer major cardiovascular events, contributed to the drop in illness-related absences.
Death rates from cervical cancer are declining, but early detection is critical to boosting outcomes and helping employers avoid costly claims.
“We are not yet seeing evidence of cost trend moderation,” Tim Noel, CEO of UnitedHealthcare, said in a July 16 earnings call.
While the new system will allow employers to dig into more granular data, it could also mean higher bills and more administrative complexities.
Frustrated by increasing friction between health systems and insurers, some employers are negotiating their own contracts with providers.
What ICHRA adoption looks like, six years after it first hit the market.
From recruiting and retention to company culture and the latest in HR tech, HR Brew delivers up-to-date industry news and tips to help HR pros stay nimble in today’s fast-changing business environment.
By subscribing, you accept our Terms & Privacy Policy.